An interventional study of My Voice website intervention with patient and caregiver modules in Kidney Failure, Chronic Therapy; Hemodialysis, sponsored by Duke-NUS Graduate Medical School. Recruiting at 1 site in Singapore. Open to participants aged 21 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-12-30.
Sponsored by Duke-NUS Graduate Medical School · Not applicable, Interventional, and Supportive care
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
'My Voice' is a website intervention developed to enable advance care planning (ACP) conversations for patients with kidney disease on dialysis, educate patients on their illness, help identify their goals and preferences for EOL care, and coaches them on how to speak with their HCPs and loved ones. This study aims to evaluate if 'My Voice' intervention improves quality of ACP conversations between patients and providers, and patients and family carers; improves patient's knowledge about kidney failure, engagement in ACP and preparedness for future end of life care compared to usual practices for ACP in dialysis centres.
1,415 studies on the registry are indexed under Renal Insufficiency; 149 are open to participants now.
This study's planned enrollment of 100 is above the median of 40 across 1,062 interventional studies indexed under Renal Insufficiency.
Browse Renal Insufficiency studies →Duke-NUS Graduate Medical School is the lead sponsor of 63 studies on the registry; 6 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Inclusion Criteria: For patients
Identified as eligible for SIC by NKF HCPs based on one or more of the following:
Inclusion Criteria: For caregivers
Exclusion Criteria: For Patients
Exclusion Criteria: For Caregivers
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.
MMSE and MoCA
Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Patients will view My Voice website intervention and complete patient module. They will also receive standard of care for advance care planning \[namely serious illness conversation (SIC)\] with the health care provider at the dialysis centers. Caregivers will view My Voice website intervention and complete caregiver module.
Other: My Voice website intervention with patient and caregiver modules
Patients will receive standard of care for advance care planning -namely the serious illness conversation (SIC) with the health care provider at the dialysis centres. Caregivers will receive no intervention.
'My Voice' is an interactive web-based ACP intervention tailored for patients with kidney failure on dialysis, and their caregivers, and includes patient and caregiver modules. Patient module has 6 steps consisting of a series of videos, value-clarification exercise (VCE) identifying goals and values for care, and knowledge quiz, and a summary My Voice document that is generated shared with patients, designated surrogates and HCPs. Automated reminders are sent to revisit My Voice. Caregiver module has 4 steps with videos and quiz, with access to their loved one's summary My Voice document containing goals of care and values.
Quality of ACP conversations (serious illness conversations) between patients and physicians/health care providers
Quality of ACP conversations will be measured using a scoring sheet developed for the study. One point will be given for every SICG topic discussed with score min to max of 0 to 13. Higher scores indicate higher quality.
Time frame: Post baseline and within 8 weeks
Change in kidney disease and dialysis knowledge scores
Collected using knowledge questions designed by the research team. Higher scores indicate higher knowledge
Time frame: Baseline to 8 weeks
Change in ACP engagement
Using the 9-item Advance care planning engagement scale. 9 to 45 (Min to Max) value, with higher value indicating higher engagement
Time frame: Baseline to 8 weeks
Change in patient preparedness
Assessed using Preparedness for end-of-life decision-making scale. 20 to 80 (min to max) scores, with higher scores indicating better preparedness
Time frame: Baseline to 8 weeks
Change in proportion of patients who had ACP conversations with family caregivers/spokesperson
Based on self-reported number of ACP conversations collected in the survey
Time frame: Baseline and 8 weeks
Plan to share: No
No publications or documents are linked to this record.
Started Oct 2025 (actual). Primary completion is estimated for Sep 2026, 11 months after the start.
Of 118 non-industry interventional studies with no phase under Renal Insufficiency, half reached primary completion within 22 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 49. This study's planned 11 months is below that.
Counting every sponsor, half of 149 studies reached it within 22 months; a quarter within 8 and three quarters within 48.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Duke-NUS Graduate Medical School